SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Deel strikes multi-year deal with Arsenal as tech firm enters global sport

Jensen Huang’s quiet role emerges as Argamani describes Nvidia’s two-year vigil for Avinatan Or

Freed Nvidia engineer Avinatan Or meets Jensen Huang at U.S. headquarters

Palo Alto Networks: Hamas-linked hackers launch stealth espionage push across Arab governments

Buzz

Most popular

Daily

Weekly

1

Oracle’s stock has fallen 40% since Safra Catz announced her exit. Its latest earnings didn’t calm investors.

2

Freed Nvidia engineer Avinatan Or meets Jensen Huang at U.S. headquarters

3

After over $390 million in funding, Believer Meats abruptly shuts down

4

Israel’s quantum boom: Startups hit $500 million in funding in 2025

5

BlackRock in talks for major investment in creative-tech firm Artlist

InMode

5 stories about InMode

משה מזרחי מייסד חברת הום סקינוביישנס

Medical Aesthetic Company InMode in Talks for Secondary Offering

23.12.19|Golan Hazani

The Israel-based company listed on Nasdaq in August at a $450 million company valuation but has since reached a $1.3 billion market capitalization

Dreams of Eternal Youth Boost InMode’s Valuation

04.11.19|Sophie Shulman

The medical aesthetic devices manufacturer doubled its market capitalization since its August IPO on Nasdaq, passing the $1 billion mark this past weekend

משה מזרחי מייסד חברת הום סקינוביישנס

Medical Aesthetic Device Manufacturer InMode Raises $70 Million on Nasdaq IPO

11.08.19|Golan Hazani

InMode priced its shares at $14, the lower end of its previously suggested range, giving the company a pre-money valuation of $378 million

Medical Aesthetic Devices Manufacturer InMode Looking to Raise $75 Million on Nasdaq

In June, Calcalist reported that InMode is looking to list on Nasdaq according to a company valuation of $400 million to $500 million

Medical Aesthetic Devices Manufacturer InMode Gearing Up for Nasdaq IPO

03.06.19|Golan Hazani

InMode develops devices that use radio-frequency energy technology, capable of penetrating subdermal fat